Name and Location
USMM Accountable Care Partners, LLC
Previous Names: N/A
500 Kirts Blvd.
Troy, MI 48084

Primary Contact
Joan Valentine
Email: jvalentine@usmmllc.com
Phone: 248-434-6222

ACP Participants

ACO Participants

ACO Participant in Joint Venture   (Enter Y or N)

VPA of Texas, PLLC

N

RMED, LLC

N

VPA, PC

N

ACO Governing Body

Member
First Name
Member Last Name 

Member Title/Position

 

Member's Voting Power

Membership Type

ACO Participant Legal Business Name and D/B/A, if applicable

Matt

Chance

Manager

10

ACO Participant Representative

RMed, LLC

Joan

Valentine

Manager

10

Other

N/A

Basil

Younis

Manager

10

ACO Participant Representative

VPA of Texas, PLLC

Zack

Mulligan

Manager

10

ACO Participant Representative

RMed, LLC

Stefanie

Cain

Manager

10

ACO Participant Representative

VPA, P.C.

Annemarie

Daily

CMO/Manager

10

ACO Participant Representative

VPA, P.C.

Margaret

Wadas-Enright

Manager

10

ACO Participant Representative

VPA of Texas, PLLC

Bhavesh

Patel

Manager

10

ACO Participant Representative

RMed, LLC

Lynn

Beatty Athens

Manager

10

ACO Participant Representative

VPA, P.C.

Ann

Pappas

Manager

10

Medicare beneficiary representative

N/A

ACO Clinical and Administrative Leadership

Key ACO Clinical and Administrative Leadership

  • Chairperson: Matt Chance
  • Vice-Chairperson: Joan Valentine
  • Treasurer: Zack Mulligan
  • Secretary: Stephanie Olsen
  • Medical Director: Annemarie Daly
  • Chief Compliance Officer: Chichi Onoriobe

Associated Committees and Committee Leaderships

  • Care Management - Care Management Eric McKeon, VP - Clinical Programs and Pharmacy
  • Quality Management & Peer Review - Joan Valentine, Exec. V.P., VPA
  • Finance - Care Management Eric McKeon, VP - Clinical Programs and Pharmacy
  • Compliance - Chichi Onoriobe, Director Quality Operations

Types of ACO Participants, or Combinations of Participants, That Formed the ACO

Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

•   Third Agreement Period
    o  Performance Year 2021, $25,813,466.19
    o  Performance Year 2020, $19,404,826.74
    o  Performance Year 2019-A, $0
•  Second Agreement Period
    o  Performance Year 2019, $0
• First Agreement Period
   o  Performance Year 2018, $12,620,610
   o  Performance Year 2017, $20,750,377
   o  Performance Year 2016, $21,195,787
   o  Performance Year 2015, $7,393,855
 

Shared Savings Distribution

  • Third Agreement Period
    • Performance Year 2021
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 15%
      • Proportion of distribution to ACO participants: 75%
      • Third Agreement Period
      • Performance Year 2020
        • Proportion invested in infrastructure: 20%
        • Proportion invested in redesigned care processes/resources: 59%
        • Proportion of distribution to ACO participants: 21%
        • Third Agreement Period
      •   Performance Year 2019-A
        • Proportion invested in infrastructure: 0%
        • Proportion invested in redesigned care processes/resources: 0%
        • Proportion of distribution to ACO participants: 0%
    • Second Agreement Period
      • Performance Year 2019
        • Proportion invested in infasinfrastructure: 0%
        • Proportion invested in redesigned care processes/resources: 0%
        • Proportion of distribution to ACO participants: 0%
    • First Agreement Period
      • Performance Year 2018
        • Proportion invested in infrastructure: 31%
        • Proportion invested in redesigned care processes/resources: 37%
        • Proportion of distribution to ACO participants: 32%
      • Performance Year 2017
        • Proportion invested in infrastructure: 14%
        • Proportion invested in redesigned care processes/resources: 67%
        • Proportion of distribution to ACO participants: 19%
      • Performance Year 2016
        • Proportion invested in infrastructure: 13%
        • Proportion invested in redesigned care processes/resources: 68%
        • Proportion of distribution to ACO participants: 19%
      • Performance Year 2015
        • Proportion invested in infrastructure: 60%
        • Proportion invested in redesigned care processes/resources: 15%
        • Proportion of distribution to ACO participants: 25%

Quality Performance Results

2021 Quality Performance Results:

Quality performance results are based on MIPS CQMs

ACO Quality Measure Number

Measure Name

Rate

ACO Mean

001

 Diabetes: Hemoglobin A1c (HbA1c) Poor

27.36

40.68

134

 Preventative Care and Screening: Screening for Depression and Follow-up

86.48

51.53

236

 Controlling High Blood Pressure

79.19

69.61

321

 CAHPS for MIPS3

N/A

N/A

479

 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for

0.1685

0.1685

MCC1

 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

39.41

33.99

CAHPS-1

 Getting Timely Care, Appointments, and

79.06

84.67

CAHPS-2

 How Well Providers Communicate

92.24

93.56

CAHPS-3

 Patient’s Rating of Provider

90.47

92.19

CAHPS-4

 Access to Specialists

71.76

78.80

CAHPS-5

 Health Promotion and Education

60.74

61.61

CAHPS-6

 Shared Decision Making

54.38

60.89

CAHPS-7

 Health Status and Functional Status

51.76

71.78

CAHPS-8

 Care Coordination

79.67

85.66

CAHPS-9

 Courteous and Helpful Office Staff

87.44

91.88

CAHPS-11

 Stewardship of Patient Resources

29.25

24.71

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-day Rule Waiver:
    • Yes, our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR 425.612.
  • Waiver for Payment for Telehealth Services:
    •  Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR 425.612(f) and 42 CFR 425.613.

Fraud and Abuse Waivers

  • ACO Pre-Participation Waiver:

The following information describes each arrangement for which our ACO seeks protection under the ACO Pre-Participation Waiver, including any material amendment or modification to a disclosed arrangement.

Not Applicable

  • ACO Participation Waiver:

The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.

MSSP Participation Waiver